EcoR1 Capital as of Dec. 31, 2024
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 57 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 14.3 | $379M | 12M | 31.91 | |
| Zymeworks Del (ZYME) | 8.3 | $220M | 15M | 14.64 | |
| Crinetics Pharmaceuticals In (CRNX) | 8.3 | $219M | 4.3M | 51.13 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 7.9 | $210M | 1.7M | 123.15 | |
| Prothena Corp SHS (PRTA) | 6.1 | $160M | 12M | 13.85 | |
| Xencor (XNCR) | 5.3 | $141M | 6.1M | 22.98 | |
| Pfizer Call Option (PFE) | 5.0 | $133M | 5.0M | 26.53 | |
| Arvinas Ord (ARVN) | 4.9 | $129M | 6.7M | 19.17 | |
| Anaptysbio Inc Common (ANAB) | 3.9 | $104M | 7.9M | 13.24 | |
| Sarepta Therapeutics (SRPT) | 3.5 | $94M | 770k | 121.59 | |
| Janux Therapeutics (JANX) | 3.0 | $79M | 1.5M | 53.54 | |
| Uniqure Nv SHS (QURE) | 2.5 | $67M | 3.8M | 17.66 | |
| Springworks Therapeutics (SWTX) | 2.1 | $56M | 1.6M | 36.13 | |
| Crispr Therapeutics Namen Akt (CRSP) | 2.1 | $55M | 1.4M | 39.36 | |
| Immunome (IMNM) | 1.6 | $41M | 3.9M | 10.62 | |
| Tectonic Therapeutic (TECX) | 1.5 | $39M | 849k | 46.17 | |
| Tango Therapeutics (TNGX) | 1.2 | $33M | 11M | 3.09 | |
| Third Harmonic Bio (THRD) | 1.2 | $33M | 3.2M | 10.29 | |
| Kura Oncology (KURA) | 1.2 | $31M | 3.6M | 8.71 | |
| Neurogene (NGNE) | 1.1 | $29M | 1.3M | 22.86 | |
| Oric Pharmaceuticals (ORIC) | 1.0 | $28M | 3.4M | 8.07 | |
| Eton Pharmaceuticals (ETON) | 1.0 | $26M | 2.0M | 13.32 | |
| Mbx Biosciences (MBX) | 0.9 | $23M | 1.3M | 18.43 | |
| Madrigal Pharmaceuticals (MDGL) | 0.9 | $23M | 75k | 308.57 | |
| Voyager Therapeutics (VYGR) | 0.8 | $22M | 3.9M | 5.67 | |
| Neumora Therapeutics (NMRA) | 0.8 | $22M | 2.1M | 10.60 | |
| Cargo Therapeutics (CRGX) | 0.8 | $21M | 1.5M | 14.42 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.7 | $18M | 333k | 54.15 | |
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.6 | $17M | 1.7M | 9.82 | |
| Avidity Biosciences Ord (RNA) | 0.6 | $16M | 558k | 29.08 | |
| Mersana Therapeutics | 0.6 | $16M | 11M | 1.43 | |
| Tscan Therapeutics (TCRX) | 0.6 | $15M | 5.0M | 3.04 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.6 | $15M | 27M | 0.54 | |
| Kymera Therapeutics (KYMR) | 0.5 | $14M | 350k | 40.23 | |
| Dyne Therapeutics (DYN) | 0.5 | $13M | 556k | 23.56 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $13M | 910k | 14.00 | |
| Atea Pharmaceuticals (AVIR) | 0.4 | $11M | 3.3M | 3.35 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $11M | 862k | 12.67 | |
| Replimune Group (REPL) | 0.4 | $10M | 850k | 12.11 | |
| Aligos Therapeutics Com New (ALGS) | 0.4 | $10M | 256k | 39.84 | |
| Atara Biotherapeutics Com New (ATRA) | 0.3 | $7.1M | 532k | 13.31 | |
| Verve Therapeutics (VERV) | 0.3 | $7.1M | 1.3M | 5.64 | |
| Fate Therapeutics (FATE) | 0.2 | $5.0M | 3.0M | 1.65 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $4.3M | 155k | 27.50 | |
| Allovir (ALVR) | 0.1 | $3.9M | 409k | 9.66 | |
| Keros Therapeutics (KROS) | 0.1 | $3.0M | 188k | 15.83 | |
| Relay Therapeutics (RLAY) | 0.1 | $2.6M | 641k | 4.12 | |
| Design Therapeutics (DSGN) | 0.1 | $2.6M | 427k | 6.17 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.1 | $2.6M | 963k | 2.66 | |
| Generation Bio | 0.1 | $2.2M | 2.0M | 1.06 | |
| Prime Medicine (PRME) | 0.1 | $2.0M | 700k | 2.92 | |
| Aadi Bioscience (WHWK) | 0.0 | $1.1M | 345k | 3.15 | |
| Upstream Bio (UPB) | 0.0 | $986k | 60k | 16.44 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $957k | 67k | 14.35 | |
| Hookipa Pharma Com New (HOOK) | 0.0 | $782k | 389k | 2.01 | |
| Artiva Biotherapeutics (ARTV) | 0.0 | $418k | 42k | 10.08 | |
| Monte Rosa Therapeutics Call Option (GLUE) | 0.0 | $151k | 22k | 6.94 |
